Thrombocytopenia and ITP: Causes, Symptoms, and Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383).
Deadline for manuscript submissions: closed (31 October 2016)
Special Issue Editors
Interests: megakaryopoiesis; thrombopoietin signaling; immune thrombocyoptenia; inherited thrombocytopenia
Interests: megakaryopoiesis; immune thrombocyoptenia; inherited thrombocytopenia; genetics of inherited thrombocytopenias
Special Issue Information
Dear Colleagues,
Thrombocytopenia encompasses a diverse range of conditions, ranging from acquired to constitutive. With the availability of high throughput molecular techniques, new insights into the etiology of immune and inherited thrombocytopenia syndromes have markedly improved our ability to diagnose and counsel patients accurately and promise to aid in the development of novel therapeutics.
This Special Issue of the Journal of Clinical Medicine will cover the following important aspects of this field:
- Molecular understanding of thrombopoiesis
- Molecular basis of inherited platelet defects
- Leukemia predisposition in inherited thrombocytopenia syndromes
- Mechanisms of immune dysregulation in immune thrombocytopenia
- New therapeutic developments
Prof. Dr. Amy E. Geddis
Dr. Michele P. Lambert
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thrombocytopenia
- megakaryopoiesis
- inherited thrombocytopenia
- thrombopoietin
- immune thrombocytopenia
- leukemia predisposition
- whole exome sequencing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
